Replies to post #379082 on Anavex Life Sciences Corp (AVXL)

[Hoskuld]

No, the trial was too small and didn't include the primary population for the indication: juveniles. Anavex is handling this perfectly. There is no reason to doubt that 2-73 will be approved for Rett after the 2nd P3 trial is analyzed and added to the eCTD.

[frrol]

The OLE results for the Rett adults would be helpful too. The company is just not being transparent here. Hopefully the pediatric and longer duration Excellence results are more completely presented.

[McMagyar]

No doc..
we wouldn’t have been approved

That BS..

Nothing was getting approved until
The AD data was discovered at the end of the this trial..

To say otherwise is BS

Man I don’t want another ignore